Abbott India has proposed a total dividend of ₹656 per share, including a final ₹525 and a special ₹131 payout. Shareholders must comply with new Income Tax Act rules by July 24, 2026, to avoid a 20% TDS.

Abbott India Proposes ₹656 Per Share Dividend, Urges Tax Compliance

Abbott India has proposed a significant dividend payout of ₹656 per share for the financial year ending March 31, 2026. This includes a final dividend of ₹525 and a special dividend of ₹131 per share. The proposal awaits member approval at the upcoming Annual General Meeting on August 13, 2026.

Reader Takeaway: Generous dividend payout; timely tax compliance is crucial for shareholders to receive full dividend amount.

What Just Happened

The Board of Directors of Abbott India Limited recommended a total dividend of ₹656 per share. This comprises a final dividend of ₹525 and a special dividend of ₹131. The company has also highlighted new tax compliance procedures under the Income Tax Act, 2025.

Why This Matters

For investors, the proposed dividend offers a direct return on their investment. However, receiving the full dividend amount is contingent upon adhering to new tax regulations. Shareholders must submit required documentation and tax declarations by July 24, 2026, to avoid a higher Tax Deducted at Source (TDS) of 20%.

The Backstory

Abbott India is a leading healthcare company in India, involved in the development, manufacturing, and marketing of a wide range of pharmaceutical and nutritional products. The company has a history of rewarding shareholders with consistent dividend payouts.

What Changes Now

Investors need to be aware of the updated tax compliance requirements. The previous Forms 15G and 15H have been replaced by a new Form 121 for resident individuals. Shareholders must ensure their PAN and other necessary tax declarations are submitted to KFin Technologies Limited (the Registrar and Transfer Agent) by July 24, 2026. The company will use the Income Tax Department's Compliance Check Functionality to determine withholding rates.

Risks to Watch

The primary risk for shareholders is non-compliance with the new tax regulations by the stipulated deadline. Failure to submit the correct documentation could lead to a higher TDS of 20%, reducing the net dividend received. The company has stated it will not refund excess taxes deducted.

Peer Comparison

While dividend announcements are common in the pharmaceutical sector, the quantum of Abbott India's proposed dividend is substantial. Companies like Pfizer India, Sanofi India, and GSK Pharma also announce dividends, but the specific payout ratios and compliance requirements can vary significantly year-on-year based on financial performance and regulatory changes.

Context Metrics

• Total Dividend Proposed: ₹656 per share
• Face Value: ₹10 per share
• Record Date: July 24, 2026
• Payment Date: On or after August 18, 2026
• AGM Date: August 13, 2026
• TDS Rate (non-compliant): 20%

What to Track Next

Investors should prioritize submitting all required tax documents by July 24, 2026. They should also track the outcome of the Annual General Meeting on August 13, 2026, where the dividend proposal will be formally approved.